Bioterror impact is false and overblown
Lentzos 17[ Filippa Lentzos, Senior research fellow jointly appointed in the Departments of War Studies and of Global Health and Social Medicine at King’s College London, 7-3-2017, "Ignore Bill Gates: Where bioweapons focus really belongs;", Bulletin of the Atomic Scientists, https://thebulletin.org/2017/07/ignore-bill-gates-where-bioweapons-focus-really-belongs/, accessed 6-28-2022]
I disagree. At a stretch, terrorists taking advantage of advances in biology might be able to create a viable pathogen. That does not mean they could create a sophisticated biological weapon, and certainly not a weapon that could kill 30 million people. Terrorists in any event tend to be conservative. They use readily available weapons that have a proven track record—not unconventional weapons that are more difficult to develop and deploy. Available evidence shows that few terrorists have ever even contemplated using biological agents, and the extremely small number of bioterrorism incidents in the historical record shows that biological agents are difficult to use as weapons. The skills required to undertake even the most basic of bioterrorism attacks are more demanding than often assumed. These technical barriers are likely to persist in the near- and medium-term future.
Gates does a disservice to the global health security community when he draws media and policy attention to amateurs such as terrorists. Where biological weapons are concerned, the focus should remain on national militaries and state-sponsored groups. These are the entities that might have the capability, now or in the near future, to develop dangerous biological weapons. The real threat is that sophisticated biological weapons will be used by state actors—or by financially, scientifically, and militarily well-resourced groups sponsored by states.